Systemic sclerosis trial design moving forward

Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward.

The neuropsychological aspects of multiple sclerosis (MS) have evolved over the past three decades. What was once thought to be a rare occurrence, cognitive dysfunction is now viewed as one of the most disabling symptoms of the disease, with devastating effects on patients' quality of life. This selective review will highlight major innovations and scientific discoveries in the areas of neuropa...

Autologous HSCT in systemic sclerosis: a step forward.

Early and rapidly progressive systemic sclerosis with skin or internal organ involvement, predominantly of the lung, is associated with 3–5-year survival of 50–80%. In the past decade, despite improved screening for systemic sclerosis and new drugs for pulmonary hypertension, no treatment has been effective for the 10–20% of patients with life-threatening disease. After the first use of haemopo...

Moving Forward

.......Having reached the end of my second term as editor in chief, the time has come for Micro to move forward to the next phase of its evolution. I am delighted to announce that Dr. Erik Altman from IBM Research is the new Micro EIC. Erik is an accomplished and highly respected industry architect and researcher who has held numerous leadership positions within the computing community. He has ...

Moving forward.

Moving Path Planning Forward

Path planning technologies have rapidly improved over the last 10 years, but further integration is needed if pathfinding engines are to drive the behavior of even more realistic characters. This paper briefly outlines existing approaches for path planning and suggests scenarios where integration of information about character’s relationships could improve the quality of path planning in games.